Status:
COMPLETED
Citicoline, Creatine, and Omega-3 Effects in Middle Age Women
Lead Sponsor:
Deborah Yurgelun-Todd
Conditions:
Cognitive Benefits
Eligibility:
FEMALE
40-60 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the functional effects of a citicoline, creatine, and omega-3 fatty acids combination when administered for a duration of four weeks (28 days) to non-psychiat...
Detailed Description
Standard clinical measures for mood and neuropsychological measures of attention, cognitive inhibition and memory will be applied before, during, and after a course of a daily supplementation of citic...
Eligibility Criteria
Inclusion
- Female
- Age 40-60 years
Exclusion
- Significant medical condition
- History of co-morbid psychiatric disorders
- Current Axis I or II diagnosis
- Past participation in a pharmacotherapeutic trial
- Head injury with LOC\>5 minutes
- Use of psychotropic medication
- History of fish allergies
- Medical condition associated with clinically significant decreases in coagulability
- Use of anticoagulant medication
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01502813
Start Date
February 1 2012
End Date
November 1 2019
Last Update
April 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Brain Institute
Salt Lake City, Utah, United States, 84108